Leading pharmaceutical companies including Novartis, Eli Lilly, Pfizer, and Bristol Myers Squibb are focused on cutting-edge oncology approaches amid projections of 2 million new cancer cases in the US.

The entities involved

• Bristol-Myers Squibb →

  American pharmaceutical company

  • Bristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Mon 13:45
  • FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09
• American Cancer Society →

  health organization seeking to cure and treat cancer

  • The American Cancer Society is advocating for pediatric cancer research funding in partnership with Rutland County.Fri 06:24
  • The American Cancer Society and National Comprehensive Cancer Network published findings in a journal regarding cancer in the United States.Thu 22:21
• Novartis →

  Swiss-American multinational pharmaceutical corporation

  • Novartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Sat 01:46
  • GSK and Novartis are identified as major pharmaceutical companies.Fri 02:16
• Pfizer PFE →

  Czech company

  Nothing else this week.

Related events

• Partnership expands Novartis's oncology pipeline.Jun 24
• Global cancer trends are informing national case projections, complicated by policy caps interacting with high treatment costs.Jul 9